Pharma deal analysis divides US FTC

Ben Remaly

18 November 2019

Pharma deal analysis divides US FTC

Credit: Pallavi Guniganti

The US Federal Trade Commission has approved Bristol-Myers Squibb’s acquisition of Celgene on a party-line vote, but both Democratic commissioners called for the agency to look more broadly at consolidation in the pharmaceutical industry.